A Phase 0 Multicenter Study of the Intratumoral Microdose Administration of PBA-0405 in Patients With Solid Tumors
Conditions: Head and Neck Squamous Cell Carcinoma; Soft Tissue Sarcoma Adult; Triple Negative Breast Cancer Interventions: Drug: PBA-0405 Sponsors: Pure Biologics S.A.; Presage Biosciences Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Breast Cancer | Breast Carcinoma | Cancer | Cancer & Oncology | Carcinoma | Head and Neck Cancer | HNSCC | Research | Sarcomas | Skin Cancer | Soft Tissue Sarcoma | Squamous Cell Carcinoma | Study